1. Home
  2. PLSE vs MMS Comparison

PLSE vs MMS Comparison

Compare PLSE & MMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$51.63

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Logo Maximus Inc.

MMS

Maximus Inc.

HOLD

Current Price

$53.22

Market Cap

3.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
MMS
Founded
2014
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
3.2B
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
PLSE
MMS
Price
$51.63
$53.22
Analyst Decision
Buy
Analyst Count
1
0
Target Price
★ $22.00
N/A
AVG Volume (30 Days)
★ 612.2K
532.9K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
★ 2.02%
EPS Growth
N/A
★ 10.42
EPS
N/A
★ 5.45
Revenue
N/A
★ $2,392,236,000.00
Revenue This Year
$840.00
$0.44
Revenue Next Year
$287.54
$5.15
P/E Ratio
★ N/A
$9.66
Revenue Growth
★ N/A
N/A
52 Week Low
$12.56
$52.03
52 Week High
$58.90
$100.00

Technical Indicators

Market Signals
Indicator
PLSE
MMS
Relative Strength Index (RSI) 54.39 35.90
Support Level $49.01 $53.19
Resistance Level $58.90 $60.42
Average True Range (ATR) 4.59 1.55
MACD -0.70 -0.47
Stochastic Oscillator 35.18 18.68

Price Performance

Historical Comparison
PLSE
MMS

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

Share on Social Networks: